Articoli di riviste sul tema "Multiple myeloma Chemotherapy"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Multiple myeloma Chemotherapy".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Durie, Brian G. M. "Chemotherapy of multiple myeloma". Baillière's Clinical Haematology 4, n. 1 (gennaio 1991): 181–95. http://dx.doi.org/10.1016/s0950-3536(05)80290-2.
Kogan, Michael, e Adnan H. Siddiqui. "Intracranial Multiple Myeloma After Chemotherapy". Archives of Clinical and Medical Case Reports 01, n. 02 (2017): 42–44. http://dx.doi.org/10.26502/acmcr.9655008.
Lokhorst, H. M., O. J. A. Th Meuwissen, E. J. E. G. Bast e A. W. Dekker. "VAD chemotherapy for refractory multiple myeloma". British Journal of Haematology 71, n. 1 (gennaio 1989): 25–30. http://dx.doi.org/10.1111/j.1365-2141.1989.tb06269.x.
Peest, D., H. J. Schmoll, I. Schedel, S. Glück, K. Schumacher e H. Deicher. "VBAMDex chemotherapy in advanced multiple myeloma*". European Journal of Haematology 40, n. 3 (24 aprile 2009): 245–49. http://dx.doi.org/10.1111/j.1600-0609.1988.tb00831.x.
Terrovitis, John V., Charis Matsouka, Athanassios Anagnostopoulos, Maria I. Anastasiou-Nana e Athanassios Meletios Dimopoulos. "Hemophagocytic Lymphohistiocytosis After Chemotherapy for Multiple Myeloma". Clinical Lymphoma 5, n. 3 (dicembre 2004): 194–96. http://dx.doi.org/10.3816/clm.2004.n.026.
Alexanian, Raymond, Bart Barlogie e Gerard Ventura. "Chemotherapy for resistant and relapsing multiple myeloma". European Journal of Haematology 43, S51 (24 aprile 2009): 140–44. http://dx.doi.org/10.1111/j.1600-0609.1989.tb01507.x.
Vidarsson, Brynjar, Svanhvit Olafsdottir e Sigrun Reykdal. "VASP Chemotherapy in Patients with Multiple Myeloma." Blood 106, n. 11 (16 novembre 2005): 5189. http://dx.doi.org/10.1182/blood.v106.11.5189.5189.
Minařík, Jiří, e Sabina Ševčíková. "Immunomodulatory Agents for Multiple Myeloma". Cancers 14, n. 23 (23 novembre 2022): 5759. http://dx.doi.org/10.3390/cancers14235759.
Katagiri, Daisuke, Eisei Noiri e Fumihiko Hinoshita. "Multiple Myeloma and Kidney Disease". Scientific World Journal 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/487285.
Bensinger, William I. "Hematopoietic Cell Transplantation for Multiple Myeloma". Cancer Control 5, n. 3 (maggio 1998): 235–42. http://dx.doi.org/10.1177/107327489800500304.
&NA;. "High-dose chemotherapy + stem cells for multiple myeloma". Inpharma Weekly &NA;, n. 1387 (maggio 2003): 13. http://dx.doi.org/10.2165/00128413-200313870-00036.
Rohatgi, Nidhi, Xianglin L. Du, Ann L. Coker, Lemuel A. Moye, Michael Wang e Shenying Fang. "Chemotherapy and Survival for Patients With Multiple Myeloma". American Journal of Clinical Oncology 30, n. 5 (ottobre 2007): 540–48. http://dx.doi.org/10.1097/coc.0b013e3180592a30.
Anderson, H., JH Scarffe, M. Ranson, R. Young, GS Wieringa, GR Morgenstern, L. Fitzsimmons e D. Ryder. "VAD chemotherapy as remission induction for multiple myeloma". British Journal of Cancer 71, n. 2 (febbraio 1995): 326–30. http://dx.doi.org/10.1038/bjc.1995.65.
Puri, Sonam, Jitesh Joshi, Olga Derman, Noah Kornblum, Amit Verma, Ira Braunschweig e Ramakrishna Battini. "Ocular Complications of Bortezomib Therapy in Multiple Myeloma". Blood 124, n. 21 (6 dicembre 2014): 5743. http://dx.doi.org/10.1182/blood.v124.21.5743.5743.
Kristinsson, Sigurdur Yngvi. "Thrombosis in Multiple Myeloma". Hematology 2010, n. 1 (4 dicembre 2010): 437–44. http://dx.doi.org/10.1182/asheducation-2010.1.437.
Chng, Wee Joo, Lee Gong Lau, Noorainun Yusof e Benjamin M. F. Mow. "Targeted Therapy in Multiple Myeloma". Cancer Control 12, n. 2 (aprile 2005): 91–104. http://dx.doi.org/10.1177/107327480501200204.
Lonial, Sagar. "Relapsed Multiple Myeloma". Hematology 2010, n. 1 (4 dicembre 2010): 303–9. http://dx.doi.org/10.1182/asheducation-2010.1.303.
Li, Juan, Junhe Li, Shaokai Luo e Yin Zhao. "Expression of TRAIL Receptors on the Multiple Myeloma Cells." Blood 104, n. 11 (16 novembre 2004): 4868. http://dx.doi.org/10.1182/blood.v104.11.4868.4868.
Luca, Dragos C., e Imad Y. Almanaseer. "Simultaneous Presentation of Multiple Myeloma and Acute Monocytic Leukemia". Archives of Pathology & Laboratory Medicine 127, n. 11 (1 novembre 2003): 1506–8. http://dx.doi.org/10.5858/2003-127-1506-spomma.
Tu, Yong-sheng, Jin He, Huan Liu, Richard Eric Davis, Robert Z. Orlowski, Joshua E. Allen e Jing Yang. "ONC201 Overcomes Chemotherapy Resistance By Upregulation of Bim in Multiple Myeloma". Blood 128, n. 22 (2 dicembre 2016): 4476. http://dx.doi.org/10.1182/blood.v128.22.4476.4476.
Mohamed, Muhajir, e Karen Dun. "Complex hypodiploid acute myeloid leukaemia secondary to chemotherapy for hyperdiploid multiple myeloma". International Journal of Hematology 100, n. 1 (13 maggio 2014): 3–6. http://dx.doi.org/10.1007/s12185-014-1594-y.
Huff, Carol Ann, e William Matsui. "Multiple Myeloma Cancer Stem Cells". Journal of Clinical Oncology 26, n. 17 (10 giugno 2008): 2895–900. http://dx.doi.org/10.1200/jco.2007.15.8428.
Todaro, Juliana, Patrícia Weinschenker Bollmann, Amit Nussbacher, Luis Fernando Aranha Camargo, Bento Fortunato Cardoso dos Santos, Daniel Alvarenga, Laercio Alberto Rosemberg, David Costa de Souza Le Bihan, Cláudio Henrique Fischer e Auro del Giglio. "Multiple myeloma complicated with pseudomonas endocartiditis". Einstein (São Paulo) 10, n. 4 (dicembre 2012): 498–501. http://dx.doi.org/10.1590/s1679-45082012000400017.
Chandran, Rekha, Miklos Simon e Stephen E. Spurgeon. "Concurrent Presentation of Hodgkin Lymphoma and Multiple Myeloma". Case Reports in Hematology 2013 (2013): 1–3. http://dx.doi.org/10.1155/2013/398769.
Berneman, Zwi N., An-Sofie Verstraete, Alain Gadisseur, Ann Van de Velde e Wilfried A. Schroyens. "The Survival of Multiple Myeloma Patients: A Single Institution Study." Blood 104, n. 11 (16 novembre 2004): 5223. http://dx.doi.org/10.1182/blood.v104.11.5223.5223.
Kaneko, Haruo, Ken Shikoshi, Shuichi Annou, Masashi Takada, Motoharu Kato, Setsuro Moro, Mikio Yamauchi e Tatsuo Shirai. "VCAP Combination Chemotherapy for Multiple Myeloma in the Aged." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 28, n. 4 (1991): 504–8. http://dx.doi.org/10.3143/geriatrics.28.504.
Johnstone, Megan, Delaney Vinaixa, Marcello Turi, Eugenio Morelli, Kenneth Carl Anderson e Annamaria Gulla. "Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma". Cells 11, n. 16 (14 agosto 2022): 2519. http://dx.doi.org/10.3390/cells11162519.
Ii, Frederick Richards, Morton Coleman, M. Robert Cooper e W. Perry Ballard. "Multiple Myeloma—Complete Remission with High Dose Melphalan Chemotherapy". Cancer Investigation 3, n. 1 (gennaio 1985): 15–21. http://dx.doi.org/10.3109/07357908509040604.
Wright, A., S. Elkins, J. Files, C. Bigelow, V. Herrin e M. Sample. "THROMBOEMBOLISM IN MULTIPLE MYELOMA PATIENTS RECEIVING THALIDOMIDE COMBINATION CHEMOTHERAPY." Journal of Investigative Medicine 55, n. 1 (gennaio 2007): S302. http://dx.doi.org/10.1097/00042871-200701010-00839.
Ucci, G., A. Riccardi, P. Dörmer, M. Danova e R. Luoni. "Early Plasma Cell Recruitment In Multiple Myeloma Following Chemotherapy". Cell Proliferation 21, n. 6 (novembre 1988): 405–9. http://dx.doi.org/10.1111/j.1365-2184.1988.tb00800.x.
Palva, I. P., P. Ahrenberg, A. Almquist, K. Ala-Harja, J. Apajalahti, H. Hallman, A. Hänninen et al. "Aggressive combination chemotherapy in multiple myeloma. A multicentre trial". Scandinavian Journal of Haematology 35, n. 2 (24 aprile 2009): 205–9. http://dx.doi.org/10.1111/j.1600-0609.1985.tb01574.x.
Palva, I. P. "Combination chemotherapy MOCCA in resistant and relapsing multiple myeloma". European Journal of Haematology 48, n. 1 (24 aprile 2009): 37–40. http://dx.doi.org/10.1111/j.1600-0609.1992.tb01791.x.
Fassas, Athanasios B. T., Trey Spencer, Raman Desikan, Maurizio Zangari, Elias Anaissie, Bart Barlogie e Guido Tricot. "Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients". British Journal of Haematology 119, n. 1 (ottobre 2002): 164–68. http://dx.doi.org/10.1046/j.1365-2141.2002.03772.x.
SWAN, GEORGE W. "Optimal Control Applications in the Chemotherapy of Multiple Myeloma". Mathematical Medicine and Biology 2, n. 3 (1985): 139–60. http://dx.doi.org/10.1093/imammb/2.3.139.
Zhan, Fenghuang, Wen Zhou, Maurizio Zangari, Hongwei Xu e Guido J. Tricot. "ALDH1 Activity Identifies Chemotherapy-Resistant Multiple Myeloma Stem Cells". Blood 118, n. 21 (18 novembre 2011): 990. http://dx.doi.org/10.1182/blood.v118.21.990.990.
Becker, Pamela S. "Genetic Predisposition for Chemotherapy-Induced Neuropathy in Multiple Myeloma". Journal of Clinical Oncology 29, n. 7 (1 marzo 2011): 783–86. http://dx.doi.org/10.1200/jco.2010.33.4771.
Song, Yan, Ning Hu, Xiaowei Song e Juhong Yang. "Hsa_Circ_0007841 Enhances Multiple Myeloma Chemotherapy Resistance Through Upregulating ABCG2". Technology in Cancer Research & Treatment 19 (1 gennaio 2020): 153303382092837. http://dx.doi.org/10.1177/1533033820928371.
Kryukov, E. V., V. N. Troyan, O. A. Rukavitsyn, S. V. Kozyrev, I. G. Daragan-Sushchov, V. P. Pop, S. A. Alekseev e E. R. Sapelnikova. "Densitometry as a monitoring method in the treatment of patients with multiple myeloma". Medical Visualization, n. 5 (28 ottobre 2018): 106–13. http://dx.doi.org/10.24835/1607-0763-2018-5-106-113.
Sinclair, David, Adel Resouly e Anne Spedding. "Stridor: unusual presentation of multiple myeloma". Journal of Laryngology & Otology 117, n. 10 (ottobre 2003): 829–31. http://dx.doi.org/10.1258/002221503770716313.
Israelyan, E. R., C. S. Golovataya, O. K. Bondarenko, A. V. Nayda e A. K. Pudeeva. "Onset of multiple myeloma with rheumatic polymyalgia". Medical Herald of the South of Russia 10, n. 4 (26 dicembre 2019): 98–104. http://dx.doi.org/10.21886/2219-8075-2019-10-4-98-104.
Palva, I. P., K. Ala-Harja, A. Almqvist, E. Elonen, H. Hallman, A. Hänninen, M. Ilvonen et al. "Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma". European Journal of Haematology 51, n. 2 (24 aprile 2009): 98–101. http://dx.doi.org/10.1111/j.1600-0609.1993.tb01600.x.
Salmon, S. E., J. J. Crowley, T. M. Grogan, P. Finley, R. P. Pugh e B. Barlogie. "Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study." Journal of Clinical Oncology 12, n. 11 (novembre 1994): 2405–14. http://dx.doi.org/10.1200/jco.1994.12.11.2405.
Coss, Alan, Chen Zhou, Michael F. Byrne e Alan A. Weiss. "Relapse of Multiple Myeloma Presenting with Biliary Obstruction". Canadian Journal of Gastroenterology 24, n. 4 (2010): 237–38. http://dx.doi.org/10.1155/2010/593859.
Sawicki, C. P., S. A. Climans, C. C. Hsia e J. A. Fraser. "Progressive multifocal leukoencephalopathy during ixazomib-based chemotherapy". Current Oncology 25, n. 1 (28 febbraio 2018): 99. http://dx.doi.org/10.3747/co.25.3674.
Haegelen, Claire, Laurent Riffaud, Marc Bernard, Beatrice Carsin-Nicol e Xavier Morandi. "Dural plasmacytoma revealing multiple myeloma". Journal of Neurosurgery 104, n. 4 (aprile 2006): 608–10. http://dx.doi.org/10.3171/jns.2006.104.4.608.
Sampat, Parth J., Maneesh Bisen, Nimisha Srivastava, Suman Rao e Teresa Gentile. "Accidental Ixazomib Overdose in a Patient With Multiple Myeloma". Journal of Investigative Medicine High Impact Case Reports 9 (gennaio 2021): 232470962110132. http://dx.doi.org/10.1177/23247096211013230.
Rathnakumar, Geeta, Kinjalka Ghosh, Nikhil Choudhary, Narendra Kamble e Nitin Inamdar. "Study of prognostic factors in multiple myeloma". International Journal of Advances in Medicine 8, n. 11 (26 ottobre 2021): 1694. http://dx.doi.org/10.18203/2349-3933.ijam20214131.
Quesada, JR, R. Alexanian, M. Hawkins, B. Barlogie, E. Borden, L. Itri e JU Gutterman. "Treatment of multiple myeloma with recombinant alpha-interferon". Blood 67, n. 2 (1 febbraio 1986): 275–78. http://dx.doi.org/10.1182/blood.v67.2.275.275.
Quesada, JR, R. Alexanian, M. Hawkins, B. Barlogie, E. Borden, L. Itri e JU Gutterman. "Treatment of multiple myeloma with recombinant alpha-interferon". Blood 67, n. 2 (1 febbraio 1986): 275–78. http://dx.doi.org/10.1182/blood.v67.2.275.bloodjournal672275.
Ostrovskyi, V. L., I. M. Skrypnyk, G. S. Maslova, O. A. Shaposhnyk e L. I. Yakymyshyna. "PECULIARITIES OF MYOCARDIAL BIOELECTRIC ACTIVITY IN PATIENTS WITH PROGRESSIVE MYLTIPLE MYELOMA RECEIVING BORTEZOMIB-CONTAINING CHEMOTHERAPY SCHEMES". Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 22, n. 3-4 (29 novembre 2022): 80–84. http://dx.doi.org/10.31718/2077-1096.22.3.4.80.